Nanovation Therapeutics Uk Ltd is a private limited company registered at Rutherford Appleton Laboratory, Harwell Oxford, Didcot OX11 0FA. Its total net worth is valued to be 0 pounds, while the fixed assets the company owns come to 0 pounds. Incorporated on 2021-12-07, this 2-year-old company is run by 2 directors and 1 secretary. Director Pieter C., appointed on 07 December 2021. Director Molly S., appointed on 07 December 2021. As far as secretaries are concerned, we can name: John W., appointed on 07 December 2021. The company is officially categorised as "research and experimental development on biotechnology" (Standard Industrial Classification: 72110). The last confirmation statement was sent on 2022-12-06 and the date for the following filing is 2023-12-20. Likewise, the annual accounts were filed on 31 December 2022 and the next filing should be sent on 30 September 2024.
Nanovation Therapeutics Uk Ltd Address / Contact
Office Address
Rutherford Appleton Laboratory
Office Address2
Harwell Oxford
Town
Didcot
Post code
OX11 0FA
Country of origin
United Kingdom
Company Information / Profile
Registration Number
13786991
Date of Incorporation
Tue, 7th Dec 2021
Industry
Research and experimental development on biotechnology
End of financial Year
31st December
Company age
3 years old
Account next due date
Mon, 30th Sep 2024 (139 days left)
Account last made up date
Sat, 31st Dec 2022
Next confirmation statement due date
Wed, 20th Dec 2023 (2023-12-20)
Last confirmation statement dated
Tue, 6th Dec 2022
Company staff
John W.
Position: Secretary
Appointed: 07 December 2021
Pieter C.
Position: Director
Appointed: 07 December 2021
Molly S.
Position: Director
Appointed: 07 December 2021
Annual reports financial information
Profit & Loss
Accounts Information Date
2022-12-31
Balance Sheet
Current Assets
112 221
Net Assets Liabilities
101 280
Other
Average Number Employees During Period
5
Creditors
101 473
Fixed Assets
90 532
Net Current Assets Liabilities
10 748
Total Assets Less Current Liabilities
101 280
Company filings
Filing category
Accounts
Address
Capital
Confirmation statement
Incorporation
Mortgage
Type
Category
Free download
SH01
Statement of Capital on 2024-02-06: 1349000.00 GBP
filed on: 16th, February 2024
capital
Free Download
(4 pages)
Type
Category
Free download
SH01
Statement of Capital on 2024-02-06: 1349000.00 GBP
filed on: 16th, February 2024
capital
Free Download
(4 pages)
SH01
Statement of Capital on 2023-11-24: 1231000.00 GBP
filed on: 29th, December 2023
capital
Free Download
(4 pages)
CS01
Confirmation statement with updates 2023-12-06
filed on: 28th, December 2023
confirmation statement
Free Download
(5 pages)
MR04
Satisfaction of charge 137869910001 in full
filed on: 13th, November 2023
mortgage
Free Download
(1 page)
MR01
Registration of charge 137869910002, created on 2023-10-30
filed on: 3rd, November 2023
mortgage
Free Download
(6 pages)
AA
Micro company accounts made up to 2022-12-31
filed on: 25th, August 2023
accounts
Free Download
(3 pages)
SH01
Statement of Capital on 2023-01-13: 1115000.00 GBP
filed on: 26th, April 2023
capital
Free Download
(3 pages)
CS01
Confirmation statement with no updates 2022-12-06
filed on: 5th, January 2023
confirmation statement
Free Download
(3 pages)
MR01
Registration of charge 137869910001, created on 2022-11-12
filed on: 14th, November 2022
mortgage
Free Download
(6 pages)
AD01
Registered office address changed from O2H Mill Tech Science Park Mill Lane Hauxton Cambridge CB22 5HX England to Rutherford Appleton Laboratory Harwell Oxford Didcot OX11 0FA on 2022-09-07
filed on: 7th, September 2022
address
Free Download
(1 page)
AD01
Registered office address changed from 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom to O2H Mill Tech Science Park Mill Lane Hauxton Cambridge CB22 5HX on 2022-05-25
filed on: 25th, May 2022
All the information provided is derived from publicly available records. Unintentional errors are possible - bizstats.co.uk is not responsible for how accurate or up to date the data is. You use the information provided at your own risk.